106 related articles for article (PubMed ID: 9615789)
21. [Prolongation of survival and antitumor activity of antitumor drugs in murine cancer cachexia model].
Nukatsuka M; Fujioka A; Saito H; Uchida J; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1996 Jun; 23(7):887-92. PubMed ID: 8678537
[TBL] [Abstract][Full Text] [Related]
22. UFT and its metabolites inhibit cancer-induced angiogenesis. Via a VEGF-related pathway.
Basaki Y; Aoyagi K; Chikahisa L; Miyadera K; Hashimoto A; Yonekura K; Okabe S; Shibata J; Wierzba K; Yamada Y
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):68-71. PubMed ID: 11098498
[TBL] [Abstract][Full Text] [Related]
23. [Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice].
Basaki Y; Yonekura K; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Aoyagi K; Yamada Y
Gan To Kagaku Ryoho; 2000 Jan; 27(1):93-8. PubMed ID: 10660738
[TBL] [Abstract][Full Text] [Related]
24. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
25. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
Harada S; Ping L; Obara T; Oikawa H; Miyata M; Matsuo M; Takahashi T; Yanagisawa T
Radiat Res; 1995 May; 142(2):232-41. PubMed ID: 7724740
[TBL] [Abstract][Full Text] [Related]
26. Long-term postoperative adjuvant chemotherapy of UFT/LV improves survival in a primary tumor resection-pulmonary metastasis model.
Sadahiro S; Suzuki T; Maeda Y; Tanaka A; Makuuchi H; Kamijo A; Murayama C
Anticancer Res; 2008; 28(4B):2045-8. PubMed ID: 18751373
[TBL] [Abstract][Full Text] [Related]
27. [Antitumor and anticachectic activity of UFT in BALB/c mice bearing colon 26 adenocarcinoma].
Nukatsuka M; Fujioka A; Saito H; Nakano K; Uchida J; Oh-ie S; Nomura N; Takeda S; Unemi N; Ishitani K
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2013-20. PubMed ID: 8085852
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
29. [Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Hoshi K; Kanbara T; Kawasaki Y; Ikeda Y; Namima T; Ohnuma T
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1315-7. PubMed ID: 17687222
[TBL] [Abstract][Full Text] [Related]
30. Preclinical analysis of the antitumor efficacy of TS-1 using human uterine cervical cancer tumor xenografts.
Nagai N; Komatsu M; Yunokawa M; Shiroyama Y; Hirata E
Oncol Rep; 2008 Nov; 20(5):1149-56. PubMed ID: 18949415
[TBL] [Abstract][Full Text] [Related]
31. [Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT].
Suemasu K; Nomoto C; Higashi Y
Gan To Kagaku Ryoho; 1982 Apr; 9(4):667-71. PubMed ID: 6820904
[TBL] [Abstract][Full Text] [Related]
32. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
Yonekura K; Basaki Y; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Wierzba K; Yamada Y
Clin Cancer Res; 1999 Aug; 5(8):2185-91. PubMed ID: 10473104
[TBL] [Abstract][Full Text] [Related]
33. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
34. Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
Morio A; Miyamoto H; Izumi H; Futagawa T; Oh T; Yamazaki A; Konno H
Surg Today; 2004; 34(10):822-7. PubMed ID: 15449150
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of the mechanism of increased antitumor activity of UFT after combined treatment with CDDP].
Oie S; Okabe H; Takeda S; Yamada Y
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1321-6. PubMed ID: 2114826
[TBL] [Abstract][Full Text] [Related]
36. Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.
Nukatsuka M; Fujioka A; Nakagawa F; Oshimo H; Kitazato K; Uchida J; Sugimoto Y; Nagayama S; Fukushima M
Int J Oncol; 2004 Dec; 25(6):1531-6. PubMed ID: 15547687
[TBL] [Abstract][Full Text] [Related]
37. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
38. Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.
Iguchi M; Matsumoto M; Hojo K; Wada T; Matsuo Y; Arimura A; Abe K
Jpn J Clin Oncol; 2009 May; 39(5):303-9. PubMed ID: 19336449
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of p53 status in non-small cell lung cancer in correlation with postoperative adjuvant therapy.
Hanaoka N; Tanaka F; Wada H
Thorac Cardiovasc Surg; 2002 Dec; 50(6):355-9. PubMed ID: 12457313
[TBL] [Abstract][Full Text] [Related]
40. [Effects of UFT on experimental liver metastases and on the immunologic capacity of the hosts].
Tsuru S; Togami M; Taniguchi M; Nomoto K
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1915-20. PubMed ID: 3132895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
